— Know what they know.
Not Investment Advice

HAE NYSE

Haemonetics Corporation
1W: +1.5% 1M: +13.4% 3M: +40.5% YTD: +50.0% 1Y: +134.1% 3Y: +34.7% 5Y: +72.8%
$119.97
+0.78 (+0.65%)
After Hours: $117.00 (-2.97, -2.48%)
Weekly Expected Move ±9.2%
$97 $108 $118 $129 $140
NYSE · Healthcare · Medical - Devices · Tech Score Strong Buy · Power 78 · $5.5B mcap · 45M float · 1.60% daily turnover · Short 46% of daily vol
Credit Risk of going bust: lower than 51% of companies Debt: 17.8% of company value Bonds: $84.5M held by 32 funds → details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $2.47 (down 98%), Haemonetics Corporation would be worth roughly what it owes.
Total debt $1.17B against a stock market value of $5.42B.
Distance to default 5.19 (Merton model): prices to 2026-10-26, balance sheet 2026-06-27, debt counted $589.6M (short-term plus half of long-term), stock volatility 48.2%; Altman Z 3.37. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

📊 Key Metrics

TTM
$1B
Revenue
+0.4% YoY
$96M
Net Income
-41.1% YoY
$291M
Free Cash Flow
+53.9% YoY
59.8%
Gross Margin
16.9%
Op. Margin
9.7%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE11.2%
ROA4.0%
ROIC10.1%

Valuation

P/E58.5
P/B6.5
EV/EBITDA17.2

Leverage

Debt/Equity1.40
Current Ratio3.08
Interest Cov.4.9x

Quality Scores

Piotroski F8/9
Altman Z2.63
Beneish M-2.87

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms